10.28.26 -- Feasibility Isn't Just A Technology Problem

In this video, Dr. Graham explains what led him to look more closely at clinical trial execution and what he uncovered when he mapped the path from sample collection to regulatory submission.

Clinical trial design doesn’t happen in a vacuum. Ignoring real-world constraints can derail your IRT strategy, and for RTSM clinical trials to succeed, operational empathy is essential.

Here, we debate sponsor-provided source document templates, weighing regulatory guidance, compliance risks, and operational impacts for smarter clinical trial documentation decisions.

Splitting payments, travel, and participant services can add work for sites. See how a connected model eases coordination and gives participants clearer support.

Jeremy Weitz breaks down the “country in a box” approach — a flexible FSP model that lets sponsors operate efficiently in countries where they lack a local footprint.

Ensure seamless, accurate global study translations and efficient localization with IQVIA eCOA, leveraging our proven vendor relationships and streamlined process to keep your study on track.

Leveraging primary care for chronic disease studies can accelerate patient identification, access to underrepresented populations, and improve retention rates.

Vanessa Gertsen acknowledges the growing number of technology and AI tools available for feasibility, but brings the discussion back to the realities facing patients and sites. Trial participation requires a major commitment from both, while sponsors are often competing for the same sites and patients.